US6743779B1
(en)
*
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US6426058B1
(en)
|
1996-03-29 |
2002-07-30 |
The Regents Of The University Of California |
Enhancement of NMR and MRI in the presence of hyperpolarized noble gases
|
EP0935415B1
(de)
*
|
1996-05-01 |
2006-11-22 |
Imarx Pharmaceutical Corp. |
In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
|
SE9604610D0
(sv)
*
|
1996-12-16 |
1996-12-16 |
Noviscens Ab |
Medical composition
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
GB9717542D0
(en)
*
|
1997-08-19 |
1997-10-22 |
Nycomed Imaging As |
Process
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6565885B1
(en)
*
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
EP1082108B1
(de)
*
|
1997-12-03 |
2002-12-18 |
Britannia Pharmaceuticals Limited |
Verwendung von phospholipiden zur herstellung eines arzneimittels zur behandlung von asthma
|
US6264991B1
(en)
*
|
1998-08-18 |
2001-07-24 |
Southern Research Institute |
Compositions and methods for treating intracellular infections
|
US6153217A
(en)
*
|
1999-01-22 |
2000-11-28 |
Biodelivery Sciences, Inc. |
Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents
|
FR2795644B1
(fr)
*
|
1999-07-02 |
2004-07-30 |
Air Liquide Sante Int |
Utilisations therapeutiques d'un melange helium/oxygene, en particulier dans le traitement de l'asthme
|
US6533554B1
(en)
*
|
1999-11-01 |
2003-03-18 |
University Of Southern California |
Thermal transpiration pump
|
US7897140B2
(en)
|
1999-12-23 |
2011-03-01 |
Health Research, Inc. |
Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
|
DK1272225T3
(da)
*
|
2000-04-12 |
2006-12-27 |
Liplasome Pharma As |
Lipidbaserede systemer til målrettet levering af diagnostiske midler
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
WO2001085136A2
(en)
|
2000-05-10 |
2001-11-15 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
US7061237B2
(en)
|
2000-07-13 |
2006-06-13 |
The Regents Of The University Of California |
Remote NMR/MRI detection of laser polarized gases
|
US6652833B2
(en)
*
|
2000-07-13 |
2003-11-25 |
The Regents Of The University Of California |
Functionalized active-nucleus complex sensor
|
EP1323415B1
(de)
*
|
2000-10-04 |
2010-01-13 |
Kyowa Hakko Kirin Co., Ltd. |
Methode zur beschichtung feiner teilchen mit einem lipidfilm
|
US6849194B2
(en)
|
2000-11-17 |
2005-02-01 |
Pcbu Services, Inc. |
Methods for preparing ethers, ether compositions, fluoroether fire extinguishing systems, mixtures and methods
|
DK1347743T3
(da)
*
|
2000-12-07 |
2006-07-03 |
Univ Utrecht Holding Bv |
Præparat til behandling af inflammatoriske lidelser
|
US6994842B2
(en)
*
|
2000-12-22 |
2006-02-07 |
Aspen Aerogels, Inc. |
Aerogel powder therapeutic agents
|
JP2004528321A
(ja)
|
2001-04-04 |
2004-09-16 |
ノルディック ワクチン テクノロジー アクティーゼルスカブ |
ステロールおよびサポニンを含むポリヌクレオチド結合複合体
|
DE10117043A1
(de)
*
|
2001-04-05 |
2002-11-07 |
Gerhard Puetz |
Verfahren zur Eliminierung von potentiell toxischen und/oder schädlichen Stoffen
|
US20030166593A1
(en)
*
|
2001-04-30 |
2003-09-04 |
Kenneth Chien |
Non-viral vesicle vector for cardiac specific gene delivery
|
EP1383480A4
(de)
*
|
2001-04-30 |
2006-05-24 |
Targeted Genetics Corp |
Lipidenthaltende arzneimittelabgabe-komplexe und herstellungsverfahren dafür
|
US6796957B2
(en)
*
|
2001-07-10 |
2004-09-28 |
Myocardial Therapeutics, Inc. |
Sterile aspiration/reinjection systems
|
DE60226251T2
(de)
*
|
2001-07-10 |
2009-05-14 |
Sonogene, LLC, Glen Ellyn |
Verbesserung der transfektion von dna in die leber
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US7125568B2
(en)
|
2001-08-23 |
2006-10-24 |
Sung Michael T |
Lipophilic drug compositions
|
US6680142B2
(en)
*
|
2001-08-24 |
2004-01-20 |
The United States Of America As Represented By The Secretary Of The Navy |
Bio-based microbattery and methods for fabrication of same
|
US20050065118A1
(en)
*
|
2001-10-16 |
2005-03-24 |
Jing Wang |
Organosulfur inhibitors of tyrosine phosphatases
|
TWI324518B
(en)
*
|
2001-12-19 |
2010-05-11 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
US20060188451A1
(en)
*
|
2001-12-21 |
2006-08-24 |
Aspen Aerogels, Inc. |
Aerogel based pharmaceutical formulations
|
CA2473521C
(en)
*
|
2002-01-22 |
2014-04-15 |
Biomatera Inc. |
Method of drying biodegradable polymers
|
JP4113361B2
(ja)
*
|
2002-02-05 |
2008-07-09 |
日立ソフトウエアエンジニアリング株式会社 |
複層半導体ナノ粒子の製造方法
|
US7407778B2
(en)
*
|
2002-02-07 |
2008-08-05 |
Pettegrew Jay W |
Compounds, compositions and methods for treating neuropsychiatric disorders
|
US7700074B2
(en)
*
|
2002-02-07 |
2010-04-20 |
Pettegrew Jay W |
Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
|
JP2005524657A
(ja)
|
2002-02-27 |
2005-08-18 |
ファーメイン, エルティーディー. |
治療剤及び他の物質を送達するための組成物、及び、前記組成物を作製し使用する方法
|
US7635463B2
(en)
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
WO2003075977A2
(en)
*
|
2002-03-05 |
2003-09-18 |
Cleveland State University |
Agglomerated particles for aerosol drug delivery
|
US20030219473A1
(en)
*
|
2002-03-26 |
2003-11-27 |
Leila Zarif |
Cochleates made with purified soy phosphatidylserine
|
WO2003082303A1
(en)
*
|
2002-03-29 |
2003-10-09 |
Wisconsin Alumni Research Foundation |
Polymeric micelle formulations of hydrophobic compounds and methods
|
US6979296B2
(en)
*
|
2002-04-03 |
2005-12-27 |
Sbm Biologics, Inc. |
Methods for ultrasonic imaging and treating diseased tissues
|
EP1499294B1
(de)
*
|
2002-04-29 |
2010-08-11 |
Biotesys Gmbh |
Polymerisierte peptid-modifizierte lipide als biologische transportsysteme für mikronutrients
|
US7060685B2
(en)
|
2002-05-16 |
2006-06-13 |
Glycomimetics, Inc. |
Compounds and methods for inhibiting selectin-mediated function
|
US8829198B2
(en)
*
|
2007-10-31 |
2014-09-09 |
Proteotech Inc |
Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
|
US20050152962A1
(en)
*
|
2002-06-12 |
2005-07-14 |
Metselaar Josbert M. |
Composition for treatment of inflammatory disorders
|
EP1517684B1
(de)
|
2002-06-27 |
2009-07-22 |
Health Research, Inc. |
Fluorinierte chlorin und bacteriochlorin photosensitizer für fotodynamische therapie
|
WO2004004636A2
(en)
*
|
2002-07-03 |
2004-01-15 |
Glycomimetics, Inc. |
Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
|
PL206594B1
(pl)
|
2002-07-15 |
2010-08-31 |
Alcon |
Kompozycja implantu śródocznego i zastosowanie leku oftalmicznego w połączeniu z niskocząsteczkowym związkiem lipofilowym do jej wytwarzania
|
US20070184089A1
(en)
*
|
2002-07-15 |
2007-08-09 |
Alcon, Inc. |
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
|
KR100434690B1
(ko)
*
|
2002-07-19 |
2004-06-04 |
소광섭 |
생명체에 대한 자기장의 영향을 측정하는 장치 및 방법
|
AU2003275009A1
(en)
*
|
2002-09-16 |
2004-04-30 |
Biotechnology Research And Development Corporation |
Methods for manufacturing polysaccharide derivatives
|
AU2003296923B2
(en)
|
2002-11-01 |
2010-03-04 |
Biodelivery Sciences International, Inc. |
Geodate delivery vehicles
|
ES2431520T3
(es)
*
|
2003-01-25 |
2013-11-26 |
Seno Medical Instruments, Inc. |
Procedimiento de formación de imágenes optoacústicas de contraste elevado utilizando nanopartículas no esféricas
|
US8017135B1
(en)
*
|
2003-01-31 |
2011-09-13 |
The Regents Of The University Of California |
Lipid-drug conjugates for local therapy of eye diseases
|
EP1590006B1
(de)
|
2003-02-04 |
2010-09-08 |
Bracco Suisse SA |
Ultraschall kontrastmittel und verfahren zur erstellung
|
EP1605922A4
(de)
*
|
2003-03-24 |
2011-03-16 |
Biosphere Medical Inc |
Temporäre embolisation mit inversen thermosensiblen polymeren
|
WO2004091578A2
(en)
*
|
2003-04-09 |
2004-10-28 |
Biodelivery Sciences International, Inc. |
Novel encochleation methods, cochleates and methods of use
|
US20050013855A1
(en)
|
2003-04-09 |
2005-01-20 |
Biodelivery Sciences International, Inc. |
Cochleate compositions directed against expression of proteins
|
US20040242886A1
(en)
*
|
2003-04-30 |
2004-12-02 |
Sandeep Gupta |
Monocyclic diazodioxide based Bcl-2 protein antagonists related applications
|
US20040248877A1
(en)
*
|
2003-04-30 |
2004-12-09 |
Sandeep Gupta |
Polycyclic diazodioxide-based Bcl-2 protein antagonists and use thereof
|
US20040219158A1
(en)
*
|
2003-05-02 |
2004-11-04 |
Glycomimetics, Inc. |
Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
|
US20060142395A1
(en)
*
|
2003-05-06 |
2006-06-29 |
University Of North Texas Health Science Center |
Modulation of intracellular calcium signaling by N-acylethanolamines
|
US20070129441A1
(en)
*
|
2003-05-06 |
2007-06-07 |
University Of North Texas Health Science Center At Fort Worth |
Protection of cells from adverse external or intrinsic effects, cellular degeneration and death by n-acylethanolamines
|
BRPI0410348A
(pt)
*
|
2003-05-14 |
2006-05-30 |
Torreypines Therapeutics Inc |
compostos e usos dos mesmos na modulação de amilóide-beta
|
US20040228800A1
(en)
*
|
2003-05-15 |
2004-11-18 |
Scicotec Gmbh |
Non-invasive identification of patients at increased risk for myocardial infarction
|
WO2004110963A2
(en)
*
|
2003-05-29 |
2004-12-23 |
Pettegrew Jay W |
Glycerophosphocholine and its derivatives for medical imaging neuropsychiatric disorders
|
US20060257842A1
(en)
*
|
2003-05-29 |
2006-11-16 |
Pettegrew Jay W |
Cryopreservation media and molecules
|
US20090227647A1
(en)
*
|
2008-03-05 |
2009-09-10 |
Thomas Lake |
Compounds, Compositions and Methods for the Treatment of Islet Amyloid Polypeptide (IAPP) Accumulation in Diabetes
|
US20100331380A1
(en)
*
|
2009-06-29 |
2010-12-30 |
Esposito Luke A |
Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies
|
US8916598B2
(en)
|
2003-05-30 |
2014-12-23 |
Proteotech Inc |
Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies
|
EP1633335A4
(de)
*
|
2003-06-19 |
2009-08-19 |
Advanced Bionutrition Corp |
Verbesserte absorption von fettlöslichen nährstoffen
|
US20060239913A1
(en)
*
|
2003-06-25 |
2006-10-26 |
Marc Port |
Peptide conjugate for magnetic resonance imaging
|
US7057100B2
(en)
*
|
2003-06-26 |
2006-06-06 |
The J.C. Robinson Seed Co. |
Inbred corn line W23129
|
US20060019868A1
(en)
*
|
2004-01-30 |
2006-01-26 |
Pendharkar Sanyog M |
Hemostatic compositions and devices
|
US8440225B2
(en)
*
|
2003-08-07 |
2013-05-14 |
Ethicon, Inc. |
Process of making flowable hemostatic compositions and devices containing such compositions
|
US7927626B2
(en)
*
|
2003-08-07 |
2011-04-19 |
Ethicon, Inc. |
Process of making flowable hemostatic compositions and devices containing such compositions
|
JP2007501797A
(ja)
*
|
2003-08-08 |
2007-02-01 |
バーンズ−ジューイッシュ ホスピタル |
造影及び治療用エマルジョン粒子並びにその使用方法
|
JP4394916B2
(ja)
*
|
2003-09-19 |
2010-01-06 |
独立行政法人科学技術振興機構 |
人工脂質二重膜の形成装置および人工脂質二重膜の形成方法、並びにその利用
|
WO2005046438A2
(en)
*
|
2003-11-06 |
2005-05-26 |
Pluromed, Inc. |
Internal clamp for surgical procedures
|
JP2007524658A
(ja)
*
|
2003-11-19 |
2007-08-30 |
グリコミメティクス, インコーポレイテッド |
E−およびp−セレクチンの両方のための糖模倣物アンタゴニスト
|
ATE383367T1
(de)
*
|
2003-11-19 |
2008-01-15 |
Glycomimetics Inc |
Spezifischer antagonist sowohl für e- als auch p- selektine
|
CA2547024C
(en)
|
2003-12-22 |
2013-12-17 |
Bracco Research Sa |
Gas-filled microvesicle assembly for contrast imaging
|
KR100638041B1
(ko)
*
|
2003-12-24 |
2006-10-23 |
주식회사 삼양사 |
수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법
|
CA2549524A1
(en)
*
|
2004-01-02 |
2005-07-28 |
Wisconsin Alumni Research Foundation |
Encapsulation of chemical compounds in fluorous-core and fluorous-inner-shell micelles formed from semifluorinated-block or fluorinated-block copolymers
|
US20050152844A1
(en)
*
|
2004-01-09 |
2005-07-14 |
Barbut Denise R. |
Transpulmonary systemic cooling using liquid mists
|
WO2005074888A2
(en)
*
|
2004-02-03 |
2005-08-18 |
Biodelivery Sciences International, Inc. |
Replacement enzyme cochleates
|
WO2005090370A1
(en)
*
|
2004-02-05 |
2005-09-29 |
The Regents Of The University Of California |
Pharmacologically active agents containing esterified phosphonates and methods for use thereof
|
US9028829B2
(en)
*
|
2004-02-20 |
2015-05-12 |
The Children's Hospital Of Philadelphia |
Uniform field magnetization and targeting of therapeutic formulations
|
US7846201B2
(en)
*
|
2004-02-20 |
2010-12-07 |
The Children's Hospital Of Philadelphia |
Magnetically-driven biodegradable gene delivery nanoparticles formulated with surface-attached polycationic complex
|
US8562505B2
(en)
|
2004-02-20 |
2013-10-22 |
The Children's Hospital Of Philadelphia |
Uniform field magnetization and targeting of therapeutic formulations
|
US20070100457A1
(en)
*
|
2004-03-04 |
2007-05-03 |
Hyde Edward R Jr |
Paramagnetic liquid interface
|
CA2562499A1
(en)
*
|
2004-04-09 |
2005-11-24 |
Biodelivery Sciences International, Inc. |
Nucleotide-cochleate compositions and methods of use
|
EP1755585A4
(de)
|
2004-05-20 |
2009-04-01 |
Scripps Research Inst |
Transthyretin-stabilisierung
|
EP3326617A1
(de)
|
2004-06-12 |
2018-05-30 |
Collegium Pharmaceutical, Inc. |
Missbrauchsverhindernde arzneimittelformulierungen
|
WO2006009876A2
(en)
*
|
2004-06-17 |
2006-01-26 |
Cengent Therapeutics, Inc. |
Trisubstituted nitrogen modulators of tyrosine phosphatases
|
US7632924B2
(en)
|
2004-06-18 |
2009-12-15 |
Ambrx, Inc. |
Antigen-binding polypeptides and their uses
|
JP2008505916A
(ja)
*
|
2004-07-09 |
2008-02-28 |
メタバシス・セラピューティクス・インコーポレイテッド |
チロシンホスファターゼの酸素/窒素複素環阻害剤
|
GB0418172D0
(en)
*
|
2004-08-13 |
2004-09-15 |
Ic Vec Ltd |
Vector
|
JP4837663B2
(ja)
|
2004-08-18 |
2011-12-14 |
ブラッコ・シュイス・ソシエテ・アノニム |
造影画像化のためのガス充填微小胞組成物
|
WO2006028970A1
(en)
*
|
2004-09-02 |
2006-03-16 |
Cengent Therapeutics, Inc. |
Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
|
NZ584773A
(en)
|
2004-09-17 |
2012-07-27 |
Whitehead Biomedical Inst |
Compounds, Compositions and Methods of Inhibiting Alpha-Synuclein Toxicity
|
US20060067889A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Light Sciences Corporation |
Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents
|
MX2007008425A
(es)
|
2005-01-13 |
2007-12-10 |
Cinv Ag |
Materiales compuestos que contienen nanoparticulas de carbono.
|
JP2006248978A
(ja)
|
2005-03-10 |
2006-09-21 |
Mebiopharm Co Ltd |
新規なリポソーム製剤
|
US20070059775A1
(en)
*
|
2005-03-29 |
2007-03-15 |
The Trustees Of Columbia University In The City Of New York |
Synthesis and conjugation of iron oxide nanoparticles to antibodies for targeting specific cells using fluorescence and MR imaging techniques
|
ATE534652T1
(de)
|
2005-04-01 |
2011-12-15 |
Univ California |
Phosphono-pent-2-en-1-yl-nukleoside und analoga
|
WO2006130217A2
(en)
*
|
2005-04-01 |
2006-12-07 |
The Regents Of The University Of California |
Substituted phosphate esters of nucleoside phosphonates
|
US8669236B2
(en)
*
|
2005-05-12 |
2014-03-11 |
The General Hospital Corporation |
Biotinylated compositions
|
US20090036386A1
(en)
*
|
2005-05-25 |
2009-02-05 |
Glycomimetics, Inc |
Heterobifunctional compounds for selectin inhibition
|
WO2007002109A2
(en)
*
|
2005-06-20 |
2007-01-04 |
The Regents Of The University Of California |
Multidentate pyrone-derived chelators for medicinal imaging and chelation
|
US7981442B2
(en)
*
|
2005-06-28 |
2011-07-19 |
University Of South Florida |
Ultrasound enhancement of drug release across non-ionic surfactant membranes
|
US8435558B1
(en)
|
2005-06-28 |
2013-05-07 |
University Of South Florida |
Ultrasound enhancement of drug release across non-ionic surfactant membranes
|
ITPD20050207A1
(it)
|
2005-07-07 |
2007-01-08 |
Fidia Farmaceutici |
Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
|
WO2007021721A2
(en)
*
|
2005-08-09 |
2007-02-22 |
Glycomimetics, Inc. |
Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
|
CN103626813B
(zh)
|
2005-09-02 |
2017-05-03 |
糖模拟物有限公司 |
异型双功能全选择素抑制剂
|
US8492428B2
(en)
*
|
2005-09-20 |
2013-07-23 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
KR20080063408A
(ko)
*
|
2005-10-18 |
2008-07-03 |
신벤션 아게 |
열경화성 수지 입자 및 이의 제조 방법
|
US20070140974A1
(en)
*
|
2005-12-15 |
2007-06-21 |
General Electric Company |
Targeted nanoparticles for magnetic resonance imaging
|
AU2006330610B2
(en)
|
2005-12-19 |
2012-08-16 |
Pharmain Corporation |
Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same
|
US8138361B2
(en)
*
|
2005-12-28 |
2012-03-20 |
The Trustees Of The University Of Pennsylvania |
C-10 carbamates of taxanes
|
DK2383271T3
(da)
*
|
2006-03-13 |
2013-10-07 |
Kyorin Seiyaku Kk |
Aminoquinoloner som GSK-3-inhibitorer
|
EP2007373A4
(de)
*
|
2006-03-29 |
2012-12-19 |
Foldrx Pharmaceuticals Inc |
Hemmung der alpha-synuclein-toxizität
|
US9789161B2
(en)
*
|
2006-04-28 |
2017-10-17 |
Warsaw Orthopedic, Inc. |
Methods for treating back or neck pain caused by NGF using a therapeutic agent consisting of ReN-1820, ALE-0540 and capsaicin
|
US20070259307A1
(en)
*
|
2006-05-03 |
2007-11-08 |
Discus Dental Impressions, Inc. |
Instruments having anti-microbial coating
|
EP2023813A4
(de)
*
|
2006-05-15 |
2013-03-13 |
Dmitri B Kirpotin |
Magnetische mikropartikel mit organischen stoffen
|
WO2007143052A1
(en)
*
|
2006-06-01 |
2007-12-13 |
Glycomimetics, Inc. |
Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
|
US20100068264A1
(en)
*
|
2006-07-12 |
2010-03-18 |
University Of South Florida |
Niosome-hydrogel drug delivery system
|
WO2008018054A2
(en)
|
2006-08-08 |
2008-02-14 |
Keter Medical Ltd. |
Imaging system
|
DK2484696T3
(en)
|
2006-08-28 |
2017-10-02 |
Kyowa Hakko Kirin Co Ltd |
Antagonistic hLIGHT-specific human monoclonal antibodies
|
PT2066662E
(pt)
|
2006-09-21 |
2013-02-13 |
Kyorin Seiyaku Kk |
Inibidores de serina-hidrolase
|
JP5298020B2
(ja)
|
2006-10-12 |
2013-09-25 |
グリコミメティクス, インコーポレイテッド |
ヘキソースおよびn−アセチルヘキソサミンの糖模倣体置換
|
JP2010507585A
(ja)
|
2006-10-19 |
2010-03-11 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
置換インドール
|
WO2008057604A2
(en)
*
|
2006-11-08 |
2008-05-15 |
The Regents Of The University Of California |
Small molecule therapeutics, syntheses of analogues and derivatives and methods of use
|
US9000048B2
(en)
*
|
2006-11-28 |
2015-04-07 |
Wisconsin Alumni Research Foundation |
Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics
|
CN101677822A
(zh)
*
|
2006-12-11 |
2010-03-24 |
普拉罗美德公司 |
灌注器官止血法
|
US20080146605A1
(en)
|
2006-12-19 |
2008-06-19 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of ccr5 inhibitors
|
CA2671766A1
(en)
*
|
2006-12-22 |
2008-07-03 |
Encysive Pharmaceuticals, Inc. |
Modulators of c3a receptor and methods of use thereof
|
US8900562B2
(en)
*
|
2007-01-12 |
2014-12-02 |
Wisconsin Alumni Research Foundation |
Semi-fluorinated block copolymers for delivery of therapeutic agents
|
US7850382B2
(en)
|
2007-01-18 |
2010-12-14 |
Sanford, L.P. |
Valve made from two materials and writing utensil with retractable tip incorporating same
|
US20080213611A1
(en)
*
|
2007-01-19 |
2008-09-04 |
Cinvention Ag |
Porous, non-degradable implant made by powder molding
|
US7488130B2
(en)
|
2007-02-01 |
2009-02-10 |
Sanford, L.P. |
Seal assembly for retractable instrument
|
NZ598863A
(en)
*
|
2007-02-09 |
2013-11-29 |
Glycomimetics Inc |
Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
|
CN101652467A
(zh)
*
|
2007-02-28 |
2010-02-17 |
金文申有限公司 |
含有填料的高表面积培养系统
|
ATE525068T1
(de)
*
|
2007-02-28 |
2011-10-15 |
Conatus Pharmaceuticals Inc |
Verfahren zur behandlung von chronischer viraler hepatitis c mithilfe von ro 113-0830
|
WO2008106167A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Conatus Pharmaceuticals, Inc. |
Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases
|
WO2008104588A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Cinvention Ag |
High surface cultivation system
|
WO2008104586A2
(en)
*
|
2007-02-28 |
2008-09-04 |
Cinvention Ag |
High surface cultivation system with surface increasing substrate
|
WO2008104599A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Cinvention Ag |
High surface cultivation system bag
|
US9814672B2
(en)
*
|
2007-03-09 |
2017-11-14 |
Susan T. Laing |
Echogenic vehicle for clinical delivery of plasminogen activator and other fibrin-binding therapeutics to thrombi
|
SI2125698T1
(sl)
|
2007-03-15 |
2016-12-30 |
Auspex Pharmaceuticals, Inc. |
Devterirani d9-venlafaksin
|
FR2914303A1
(fr)
|
2007-03-28 |
2008-10-03 |
Guerbet Sa |
Composes pour le diagnostic de l'apoptose.
|
FR2914304B1
(fr)
|
2007-03-28 |
2012-11-16 |
Guerbet Sa |
Composes pour le diagnostic de maladies liees a l'expression de vcam.
|
US7892776B2
(en)
|
2007-05-04 |
2011-02-22 |
The Regents Of The University Of California |
Screening assay to identify modulators of protein kinase A
|
US20080287931A1
(en)
*
|
2007-05-18 |
2008-11-20 |
Jones Dennis R |
Use of iontophoresis and ultrasound to deliver melanin or other chromophores for laser hair removal
|
BRPI0814542A2
(pt)
*
|
2007-07-12 |
2014-09-30 |
Tragara Pharmaceuticals Inc |
Métodos e composições para o tratamento de câncer, tumores e desordens relacionadas a tumores
|
US8039442B2
(en)
*
|
2007-07-18 |
2011-10-18 |
Glycomimetics, Inc. |
Compounds and methods for treatment of sickle cell disease or complications associated therewith
|
US7960336B2
(en)
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
US8563527B2
(en)
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
MX2010002667A
(es)
*
|
2007-09-11 |
2010-04-01 |
Activx Biosciences Inc |
Cianoaminoquinolonas y tetrazoloaminoquinolonas como inhibidores de gsk-3.
|
MX2010002662A
(es)
|
2007-09-12 |
2010-04-09 |
Activx Biosciences Inc |
Aminoquinolonas espirociclicas como inhibidores de gsk-3.
|
WO2009036368A2
(en)
*
|
2007-09-14 |
2009-03-19 |
Nitto Denko Corporation |
Drug carriers
|
EP2348052A3
(de)
|
2007-09-17 |
2011-10-26 |
The Regents of The University of California |
Auf Prostatazellen in situ abzielende internalisierende humane monoklonale Antikörper
|
WO2009042972A1
(en)
*
|
2007-09-26 |
2009-04-02 |
Tufts University |
Fluorinated lipids and methods of use
|
US20090191244A1
(en)
*
|
2007-09-27 |
2009-07-30 |
Children's Medical Center Corporation |
Microbubbles and methods for oxygen delivery
|
US20090264421A1
(en)
*
|
2007-10-05 |
2009-10-22 |
Bible Keith C |
Methods and Compositions for Treating Cancer
|
SG186008A1
(en)
*
|
2007-11-21 |
2012-12-28 |
Pharmaxis Ltd |
Haloallylamine inhibitors of ssao/vap-1 and uses therefor
|
IL188647A0
(en)
*
|
2008-01-08 |
2008-11-03 |
Orina Gribova |
Adaptable structured drug and supplements administration system (for oral and/or transdermal applications)
|
US20090176892A1
(en)
|
2008-01-09 |
2009-07-09 |
Pharmain Corporation |
Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|
MY161576A
(en)
|
2008-03-17 |
2017-04-28 |
Ambit Biosciences Corp |
Quinazoline derivatives as raf kinase modulators and methods of use thereof
|
US8226312B2
(en)
|
2008-03-28 |
2012-07-24 |
Sanford, L.P. |
Valve door having a force directing component and retractable instruments comprising same
|
WO2009126556A1
(en)
|
2008-04-08 |
2009-10-15 |
Glycomimetics, Inc. |
Pan-selectin inhibitor with enhanced pharmacokinetic activity
|
EP2123258A1
(de)
*
|
2008-05-23 |
2009-11-25 |
Liplasome Pharma A/S |
Liposomen zur Arzneimittelverabreichung
|
EP2318015B1
(de)
*
|
2008-06-13 |
2013-08-07 |
GlycoMimetics, Inc. |
Behandlung von blutkrebs mit ausgewählten glykomimetischen verbindungen
|
TW201004646A
(en)
*
|
2008-07-30 |
2010-02-01 |
Nitto Denko Corp |
Drug carriers
|
US20120034155A1
(en)
*
|
2010-08-03 |
2012-02-09 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Artificial cells
|
CN101658533A
(zh)
*
|
2008-08-29 |
2010-03-03 |
首都医科大学宣武医院 |
抗肿瘤药物的干细胞递送
|
US20100069827A1
(en)
|
2008-09-12 |
2010-03-18 |
Barry Neil Silberg |
Pre-Surgical Prophylactic Administration of Antibiotics and Therapeutic Agents
|
US9446227B2
(en)
|
2008-09-12 |
2016-09-20 |
Sonescence, Inc. |
Ultrasonic dispersion of compositions in tissue
|
US8221012B2
(en)
|
2008-11-07 |
2012-07-17 |
Sanford, L.P. |
Retractable instruments comprising a one-piece valve door actuating assembly
|
EP2398466B1
(de)
|
2008-11-24 |
2021-02-17 |
Massachusetts Institute of Technology |
Verfahren und zusammensetzungen zur lokalisierten nanopartikel-abgabe an tumoren
|
WO2010088450A2
(en)
|
2009-01-30 |
2010-08-05 |
Celladon Corporation |
Methods for treating diseases associated with the modulation of serca
|
US8393814B2
(en)
|
2009-01-30 |
2013-03-12 |
Sanford, L.P. |
Retractable instrument having a two stage protraction/retraction sequence
|
US8568793B2
(en)
|
2009-02-11 |
2013-10-29 |
Hope Medical Enterprises, Inc. |
Sodium nitrite-containing pharmaceutical compositions
|
SI2401267T1
(sl)
|
2009-02-27 |
2014-05-30 |
Ambit Biosciences Corporation |
Derivati kinazolina, ki modulirajo JAK-kinazo, in njihova uporaba v postopkih
|
EP2403860B1
(de)
|
2009-03-04 |
2015-11-04 |
IDENIX Pharmaceuticals, Inc. |
Phosphothiophene und phosphothiazole als hcv polymerase inhibitoren
|
CN102421784B
(zh)
*
|
2009-03-11 |
2015-09-30 |
杏林制药株式会社 |
作为gsk-3抑制剂的7-环烷基氨基喹诺酮
|
WO2010105016A1
(en)
|
2009-03-11 |
2010-09-16 |
Ambit Biosciences Corp. |
Combination of an indazolylaminopyrrolotriazine and taxane for cancer treatment
|
WO2010110686A1
(en)
|
2009-03-27 |
2010-09-30 |
Pathway Therapeutics Limited |
Pyrimidinyl and 1,3,5 triazinyl benzimidazoles and their use in cancer therapy
|
SG174527A1
(en)
|
2009-03-27 |
2011-11-28 |
Pathway Therapeutics Inc |
Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
|
EP2421829B1
(de)
|
2009-04-22 |
2015-09-30 |
Axikin Pharmaceuticals, Inc. |
2,5-disubstituierte arylsulfonamide als ccr3-antagonisten
|
ES2664984T3
(es)
|
2009-04-22 |
2018-04-24 |
SMA Therapeutics, Inc. |
Arilsulfonamidas 2,5-disustituidas antagonistas de CCR3
|
PE20120811A1
(es)
|
2009-04-22 |
2012-07-08 |
Axikin Pharmaceuticals Inc |
Antagonistas ccr3 arilsulfonamida
|
WO2010126888A1
(en)
*
|
2009-05-01 |
2010-11-04 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
|
CA3045126A1
(en)
*
|
2009-05-05 |
2010-11-11 |
Arbutus Biopharma Corporation |
Methods of delivering oligonucleotides to immune cells
|
US20100324124A1
(en)
*
|
2009-06-17 |
2010-12-23 |
Massachusetts Institute Of Technology |
Compositions and methods relating to DNA-based particles
|
US20100323018A1
(en)
*
|
2009-06-17 |
2010-12-23 |
Massachusetts Institute Of Technology |
Branched DNA/RNA monomers and uses thereof
|
WO2011003870A2
(en)
|
2009-07-06 |
2011-01-13 |
Creabilis S.A. |
Mini-pegylated corticosteroids, compositions including same, and methods of making and using same
|
US8486939B2
(en)
|
2009-07-07 |
2013-07-16 |
Pathway Therapeutics Inc. |
Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
|
HUE035519T2
(en)
|
2009-07-08 |
2018-05-02 |
Hope Medical Entpr Inc D B A Hope Pharmaceuticals |
Sodium thiosulfate-containing pharmaceutical composition
|
EP2451442A4
(de)
|
2009-07-09 |
2014-02-12 |
Oshadi Drug Administration Ltd |
Matrixträgerzusammensetzungen, verfahren und verwendungen
|
US8404728B2
(en)
|
2009-07-30 |
2013-03-26 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
WO2011017389A1
(en)
|
2009-08-05 |
2011-02-10 |
Idenix Pharmaceuticals, Inc. |
Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv
|
KR20120059558A
(ko)
|
2009-08-19 |
2012-06-08 |
암비트 바이오사이언시즈 코포레이션 |
바이아릴 화합물 및 이의 사용 방법
|
TW201120037A
(en)
*
|
2009-10-26 |
2011-06-16 |
Sunesis Pharmaceuticals Inc |
Compounds and methods for treatment of cancer
|
WO2011056764A1
(en)
|
2009-11-05 |
2011-05-12 |
Ambit Biosciences Corp. |
Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
|
EP2499282B1
(de)
|
2009-11-09 |
2015-04-22 |
NeuroGenetic Pharmaceuticals, Inc. |
Gamma-sekretase-modulierende verbindungen, verfahren zu ihrer identifikation und verwendungen dafür
|
WO2011069002A1
(en)
|
2009-12-02 |
2011-06-09 |
Alquest Therapeutics, Inc. |
Organoselenium compounds and uses thereof
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
US20110144216A1
(en)
*
|
2009-12-16 |
2011-06-16 |
Honeywell International Inc. |
Compositions and uses of cis-1,1,1,4,4,4-hexafluoro-2-butene
|
MX2012006877A
(es)
|
2009-12-18 |
2012-08-31 |
Idenix Pharmaceuticals Inc |
Inhibidores de virus de hepatitis c de arileno o heteroarileno 5, 5 - fusionado.
|
SG181896A1
(en)
*
|
2009-12-23 |
2012-07-30 |
Map Pharmaceuticals Inc |
Novel ergoline analogs
|
WO2011094890A1
(en)
|
2010-02-02 |
2011-08-11 |
Argusina Inc. |
Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
|
WO2011109345A1
(en)
|
2010-03-02 |
2011-09-09 |
Axikin Pharmaceuticals, Inc. |
Isotopically enriched arylsulfonamide ccr3 antagonists
|
WO2011112689A2
(en)
|
2010-03-11 |
2011-09-15 |
Ambit Biosciences Corp. |
Saltz of an indazolylpyrrolotriazine
|
AU2011227232B2
(en)
|
2010-03-17 |
2015-07-09 |
Axikin Pharmaceuticals Inc. |
Arylsulfonamide CCR3 antagonists
|
EP2547327B1
(de)
*
|
2010-03-19 |
2018-09-05 |
Massachusetts Institute of Technology |
Lipidvesikelzusammensetzungen und verfahren zu ihrer verwendung
|
US20110229556A1
(en)
*
|
2010-03-19 |
2011-09-22 |
Massachusetts Institute Of Technology |
Lipid-coated polymer particles for immune stimulation
|
US9149432B2
(en)
*
|
2010-03-19 |
2015-10-06 |
Massachusetts Institute Of Technology |
Lipid vesicle compositions and methods of use
|
WO2011150201A2
(en)
|
2010-05-27 |
2011-12-01 |
Ambit Biosciences Corporation |
Azolyl amide compounds and methods of use thereof
|
WO2011150198A1
(en)
|
2010-05-27 |
2011-12-01 |
Ambit Biosciences Corporation |
Azolyl urea compounds and methods of use thereof
|
CN104926722A
(zh)
|
2010-06-01 |
2015-09-23 |
拜欧赛里克斯公司 |
羟基吡啶酮衍生物、其药物组合物及其用于治疗增生性疾病的治疗用途
|
CN103153309A
(zh)
|
2010-06-01 |
2013-06-12 |
拜欧赛里克斯公司 |
使用6-环己基-1-羟基-4-甲基-2(1h)-吡啶酮治疗血液恶性肿瘤的方法
|
CN104860907A
(zh)
|
2010-06-07 |
2015-08-26 |
诺沃梅迪科斯有限公司 |
呋喃基化合物及其用途
|
EP2595615A1
(de)
|
2010-07-19 |
2013-05-29 |
Summa Health System |
Vitamin c und chromfreies vitamin k sowie zusammensetzungen daraus zur behandlung von nfkb-induzierten leiden oder erkrankungen
|
CA2809994A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
|
MX2013002384A
(es)
|
2010-09-01 |
2013-07-05 |
Ambit Biosciences Corp |
Compuestos quinazolina y metodos para utilizarlos.
|
US20130303533A1
(en)
|
2010-09-01 |
2013-11-14 |
Ambit Biosciences Corporation |
Azolopyridine and azolopyrimidine compounds and methods of use thereof
|
WO2012030944A2
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
Quinoline and isoquinoline compounds and methods of use thereof
|
EP2611793A1
(de)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
2-cyclochinazolinderivate und verwendungsverfahren dafür
|
WO2012030912A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
7-cyclylquinazoline derivatives and methods of use thereof
|
EP2611792B1
(de)
|
2010-09-01 |
2017-02-01 |
Ambit Biosciences Corporation |
Hydrobromid salze einer pyrazolylaminoquinazolin
|
US20130225614A1
(en)
|
2010-09-01 |
2013-08-29 |
Ambit Biosciences Corporation |
4-azolylaminoquinazoline derivatives and methods of use thereof
|
EP2611812A1
(de)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
Thienopyridin- und thienopyrimidinverbindungen sowie verfahren zu ihrer verwendung
|
WO2012030918A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
Adenosine a3 receptor modulating compounds and methods of use thereof
|
US8921328B2
(en)
|
2010-09-14 |
2014-12-30 |
Glycomimetics, Inc. |
E-selectin antagonists
|
WO2012044641A1
(en)
|
2010-09-29 |
2012-04-05 |
Pathway Therapeutics Inc. |
1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
|
US20120088769A1
(en)
|
2010-10-11 |
2012-04-12 |
Axikin Pharmaceuticals, Inc. |
Salts of arylsulfonamide ccr3 antagonists
|
AU2011338530B2
(en)
|
2010-12-06 |
2017-06-15 |
Follica, Inc. |
Methods for treating baldness and promoting hair growth
|
WO2012080050A1
(en)
|
2010-12-14 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Solid forms of a phenoxybenzenesulfonyl compound
|
EP2826468A1
(de)
|
2010-12-22 |
2015-01-21 |
Purdue Pharma L.P. |
Gekapselte manipulationssichere Darreichungsformen mit gesteuerter Freisetzung
|
CN103327969A
(zh)
|
2010-12-23 |
2013-09-25 |
普渡制药公司 |
抗篡改固体口服剂型
|
WO2012103165A2
(en)
|
2011-01-26 |
2012-08-02 |
Kolltan Pharmaceuticals, Inc. |
Anti-kit antibodies and uses thereof
|
CA2825152A1
(en)
|
2011-01-31 |
2012-08-09 |
Celgene Corporation |
Pharmaceutical compositions of cytidine analogs and methods of use thereof
|
US9353100B2
(en)
|
2011-02-10 |
2016-05-31 |
Idenix Pharmaceuticals Llc |
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
|
CN105388287A
(zh)
|
2011-03-11 |
2016-03-09 |
内布拉斯加大学董事委员会 |
冠状动脉疾病的生物标志物
|
BR112013024907A2
(pt)
|
2011-03-28 |
2016-12-20 |
Mei Pharma Inc |
composto, composição farmacêutica, método para o tratamento, prevenção ou atenuação de um ou mais sintomas de um distúrbio, doença ou condição mediada por pi3k em um sujeito, método para modular a atividade enzimática de pi3k
|
CA2831590A1
(en)
|
2011-03-28 |
2012-10-04 |
Mei Pharma, Inc. |
(alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
|
EP2691388A1
(de)
|
2011-03-28 |
2014-02-05 |
MEI Pharma, Inc. |
(kondensierte arylamino- und heterocyclylamino-)pyrimidynyl und 1,3,5-triazinyl-benzimidazole, pharmazeutische zusammensetzungen daraus und ihre verwendung zur behandlung von proliferativen erkrankungen
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
MX2013015373A
(es)
|
2011-06-23 |
2014-02-11 |
Map Pharmaceuticals Inc |
Nuevos analogos de fluoroergolina.
|
WO2013037482A1
(en)
|
2011-09-15 |
2013-03-21 |
Phenex Pharmaceuticals Ag |
Farnesoid x receptor agonists for cancer treatment and prevention
|
MX368081B
(es)
|
2011-10-14 |
2019-09-19 |
Ambit Biosciences Corp |
Compuestos heterociclicos y uso de los mismos como moduladores del receptor de tirosina cinasas tipo iii.
|
SG11201403434YA
(en)
|
2011-12-19 |
2014-09-26 |
Map Pharmaceuticals Inc |
Novel iso-ergoline derivatives
|
AU2012355983A1
(en)
|
2011-12-21 |
2015-01-22 |
Map Pharmaceuticals, Inc. |
Novel neuromodulatory compounds
|
PL2794626T6
(pl)
|
2011-12-22 |
2020-11-02 |
Glycomimetics, Inc. |
Związki antagonistyczne E-selektyny
|
WO2013130600A1
(en)
|
2012-02-29 |
2013-09-06 |
Ambit Biosciences Corporation |
Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith
|
WO2013138613A1
(en)
|
2012-03-16 |
2013-09-19 |
Axikin Pharmaceuticals, Inc. |
3,5-diaminopyrazole kinase inhibitors
|
WO2013151682A1
(en)
|
2012-04-06 |
2013-10-10 |
Children's Medical Center Corporation |
Process for forming microbubbles with high oxygen content and uses thereof
|
LT2844637T
(lt)
|
2012-05-02 |
2018-05-10 |
Boehringer Ingelheim International Gmbh |
Pakeistieji 3-haloalilamino ssao inhibitoriai ir jų panaudojimas
|
US9320750B2
(en)
*
|
2012-05-11 |
2016-04-26 |
Massachusetts Institute Of Technology |
Compositions and methods of treatment of drug resistant cancers
|
WO2013188470A1
(en)
*
|
2012-06-11 |
2013-12-19 |
The Regents Of The University Of California |
Method and system for in vivo hydrogen peroxide detection with ultrasound
|
EP3406598B1
(de)
|
2012-06-14 |
2020-01-29 |
Mayo Foundation for Medical Education and Research |
Pyrazolderivate als hemmer von stat3
|
US9012640B2
(en)
|
2012-06-22 |
2015-04-21 |
Map Pharmaceuticals, Inc. |
Cabergoline derivatives
|
DK3381943T3
(da)
|
2012-07-25 |
2022-05-16 |
Celldex Therapeutics Inc |
Anti-kit-antistoffer og anvendelser deraf
|
US20150297725A1
(en)
*
|
2012-07-30 |
2015-10-22 |
Rutgers, The State University Of New Jersey |
Cochleates made with soy phosphatidylserine
|
US9074186B2
(en)
|
2012-08-15 |
2015-07-07 |
Boston Medical Center Corporation |
Production of red blood cells and platelets from stem cells
|
AU2013308519A1
(en)
|
2012-08-31 |
2015-04-09 |
The General Hospital Corporation |
Biotin complexes for treatment and diagnosis of Alzheimer's disease
|
TW201414721A
(zh)
|
2012-09-07 |
2014-04-16 |
Axikin Pharmaceuticals Inc |
同位素濃化之芳磺醯胺ccr3拮抗劑
|
WO2014055647A1
(en)
|
2012-10-03 |
2014-04-10 |
Mei Pharma, Inc. |
(sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases
|
US20150272924A1
(en)
|
2012-11-08 |
2015-10-01 |
Summa Health System |
Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing
|
CN104955801B
(zh)
|
2012-11-30 |
2017-10-31 |
诺沃梅迪科斯有限公司 |
取代的二芳基磺酰胺及其用途
|
HUE038423T2
(hu)
|
2012-12-07 |
2018-10-29 |
Glycomimetics Inc |
E-szelektin antagonistákat felhasználó vegyületek, készítmények és eljárások vérképzõ sejtek mobilizációjára
|
BR112015014964A2
(pt)
|
2012-12-21 |
2017-07-11 |
Map Pharmaceuticals Inc |
novos derivados de metisergida
|
US9169214B2
(en)
|
2012-12-21 |
2015-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
|
EP2943188A1
(de)
|
2013-01-11 |
2015-11-18 |
Mayo Foundation for Medical Education and Research |
Vitamine c und k zur behandlung polyzystischer erkrankungen
|
US9101745B2
(en)
|
2013-03-14 |
2015-08-11 |
Sonogene Llc |
Sonochemical induction of ABCA1 expression and compositions therefor
|
US10577554B2
(en)
|
2013-03-15 |
2020-03-03 |
Children's Medical Center Corporation |
Gas-filled stabilized particles and methods of use
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
ES2891755T3
(es)
|
2013-06-06 |
2022-01-31 |
Pf Medicament |
Anticuerpos anti-C10orf54 y utilizaciones de los mismos
|
RU2016111675A
(ru)
|
2013-08-30 |
2017-10-04 |
Эмбит Байосайенсиз Корпорейшн |
Соединения биарилацетамида и способы их применения
|
NZ631142A
(en)
|
2013-09-18 |
2016-03-31 |
Axikin Pharmaceuticals Inc |
Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
|
EP3046924A1
(de)
|
2013-09-20 |
2016-07-27 |
IDENIX Pharmaceuticals, Inc. |
Inhibitoren des hepatitis-c-virus
|
CA3191031A1
(en)
|
2013-09-27 |
2015-04-02 |
Massachusetts Institute Of Technology |
Carrier-free biologically-active protein nanostructures
|
US10272117B2
(en)
|
2014-02-24 |
2019-04-30 |
Celgene Corporation |
Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
US20170066779A1
(en)
|
2014-03-05 |
2017-03-09 |
Idenix Pharmaceuticals Llc |
Solid forms of a flaviviridae virus inhibitor compound and salts thereof
|
MX2016012097A
(es)
|
2014-03-20 |
2017-04-27 |
Capella Therapeutics Inc |
Derivados de bencimidazol como inhibidores de tirosina cinasa erbb para el tratamiento del cáncer.
|
KR102409739B1
(ko)
|
2014-03-20 |
2022-06-17 |
카펠라 테라퓨틱스, 인크. |
암 치료용의 erbb 티로신 키나제 억제제로서의 벤즈이미다졸 유도체
|
US9522114B1
(en)
|
2014-03-27 |
2016-12-20 |
University Of South Florida |
Enhanced targeted drug delivery system via chitosan hydrogel and chlorotoxin
|
ES2751652T3
(es)
|
2014-05-12 |
2020-04-01 |
Conatus Pharmaceuticals Inc |
Tratamiento con inhibidor de caspasa emricasan de las complicaciones por las enfermedades hepáticas crónicas
|
MA47849A
(fr)
|
2014-05-28 |
2020-01-29 |
Agenus Inc |
Anticorps anti-gitr et leurs procédés d'utilisation
|
US9956388B2
(en)
|
2014-06-04 |
2018-05-01 |
Sonescence, Inc. |
Systems and methods for therapeutic agent delivery
|
WO2015195474A1
(en)
|
2014-06-18 |
2015-12-23 |
Biotheryx, Inc. |
Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseases
|
US9499514B2
(en)
|
2014-07-11 |
2016-11-22 |
Celgene Corporation |
Antiproliferative compounds and methods of use thereof
|
JP6543342B2
(ja)
|
2014-08-14 |
2019-07-10 |
アルハマドシャー,マモウン,エム. |
血清半減期を延長するための、調節可能リンカーを介した薬学的活性剤とトランスサイレチンリガンドのコンジュゲーション
|
CA2960284A1
(en)
|
2014-09-12 |
2016-03-17 |
Tobira Therapeutics, Inc. |
Cenicriviroc combination therapy for the treatment of fibrosis
|
WO2016065264A1
(en)
|
2014-10-24 |
2016-04-28 |
Biogen Ma Inc. |
Diterpenoid derivatives and methods of use thereof
|
SI3227310T1
(sl)
|
2014-12-03 |
2019-11-29 |
Glycomimetics Inc |
Heterobifunkcionalni inhibitorji e-selektinov in receptorjev kemokina CXCR4
|
PT3800202T
(pt)
|
2014-12-11 |
2023-01-05 |
Pf Medicament |
Anticorpos anti-c10orf54 e suas utilizações
|
EP3237450B1
(de)
|
2014-12-22 |
2021-03-03 |
The Rockefeller University |
Anti-mertk-antikörper und verwendungen davon
|
TWI703133B
(zh)
|
2014-12-23 |
2020-09-01 |
美商艾克斯基製藥公司 |
3,5-二胺基吡唑激酶抑制劑
|
JP6856532B2
(ja)
|
2015-01-20 |
2021-04-07 |
エックスオーシー ファーマシューティカルズ インコーポレイテッドXoc Pharmaceuticals, Inc |
エルゴリン化合物およびその使用
|
US9676776B2
(en)
|
2015-01-20 |
2017-06-13 |
Xoc Pharmaceuticals, Inc. |
Isoergoline compounds and uses thereof
|
CN107428749B
(zh)
|
2015-01-28 |
2020-07-24 |
上海复旦张江生物医药股份有限公司 |
取代的咪唑并[1,2-α]吡啶-2-基胺化合物及其药物组合物和使用方法
|
BR112017015880A2
(pt)
|
2015-03-03 |
2018-07-31 |
Kymab Ltd |
anticorpos, usos e métodos
|
PE20180672A1
(es)
|
2015-05-29 |
2018-04-19 |
Agenus Inc |
Anticuerpos anti-ctla-4 y metodos de uso de los mismos
|
WO2016205824A1
(en)
|
2015-06-19 |
2016-12-22 |
Neural Analytics, Inc. |
Transcranial doppler probe
|
MX2017017015A
(es)
|
2015-06-23 |
2018-02-26 |
Neurocrine Biosciences Inc |
Inhibidores de transportador de monoamina vesicular tipo 2 (vmat2) para tratar enfermedades o trastornos neurologicos.
|
CA2995212A1
(en)
|
2015-08-12 |
2017-02-16 |
Massachusetts Institute Of Technology |
Cell surface coupling of nanoparticles
|
WO2017040790A1
(en)
|
2015-09-01 |
2017-03-09 |
Agenus Inc. |
Anti-pd-1 antibodies and methods of use thereof
|
CN115322188A
(zh)
|
2015-10-30 |
2022-11-11 |
纽罗克里生物科学有限公司 |
Valbenazine盐及其多晶形物
|
WO2017079566A1
(en)
|
2015-11-05 |
2017-05-11 |
Conatus Pharmaceuticals, Inc. |
Caspase inhibitors for use in the treatment of liver cancer
|
US11474102B2
(en)
*
|
2015-11-23 |
2022-10-18 |
Massachusetts Institute Of Technology |
Protein corona phase molecular recognition
|
CA3006759A1
(en)
|
2015-11-30 |
2017-06-08 |
The Regents Of The University Of California |
Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen
|
US10112924B2
(en)
|
2015-12-02 |
2018-10-30 |
Astraea Therapeutics, Inc. |
Piperdinyl nociceptin receptor compounds
|
CN108925135A
(zh)
|
2015-12-23 |
2018-11-30 |
纽罗克里生物科学有限公司 |
制备(S)-(2R,3R,11bR)-3-异丁基-9,10-二甲氧基-2,3,4,6,7,11b-六氢-1H-吡啶并[2,1-a]异喹啉-2-基2-氨基-3-甲基丁酸酯二(4-甲基苯磺酸盐)的合成方法
|
WO2017117478A1
(en)
|
2015-12-31 |
2017-07-06 |
Conatus Pharmaceuticals Inc. |
Methods of using caspase inhibitors in treatment of liver disease
|
US11589836B2
(en)
|
2016-01-05 |
2023-02-28 |
Novasignal Corp. |
Systems and methods for detecting neurological conditions
|
WO2017120388A1
(en)
|
2016-01-05 |
2017-07-13 |
Neural Analytics, Inc. |
Systems and methods for determining clinical indications
|
WO2017120361A1
(en)
|
2016-01-05 |
2017-07-13 |
Neural Analytics, Inc. |
Integrated probe structure
|
ES2957477T3
(es)
|
2016-01-08 |
2024-01-19 |
Celgene Corp |
Compuestos antiproliferativos para usar en el tratamiento de leucemia
|
WO2017120415A1
(en)
|
2016-01-08 |
2017-07-13 |
Celgene Corporation |
Solid forms of 2-(4-chlorophenyl)-n-((2-2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl) methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses
|
EP3405473A1
(de)
|
2016-01-22 |
2018-11-28 |
GlycoMimetics, Inc. |
Glycomimetische inhibitoren von pa-il- und pa-iil-lectinen
|
US11291678B2
(en)
|
2016-03-02 |
2022-04-05 |
Glycomimetics, Inc |
Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
|
WO2017151836A1
(en)
|
2016-03-04 |
2017-09-08 |
East Carolina University |
J-series prostaglandin-ethanolamides as novel therapeutics for skin and/or oral disorders
|
WO2017156191A1
(en)
|
2016-03-08 |
2017-09-14 |
Los Gatos Pharmaceuticals, Inc. |
Composite nanoparticles and uses thereof
|
US10407437B2
(en)
|
2016-03-08 |
2019-09-10 |
Los Gatos Pharmaceuticals, Inc. |
Camptothecin derivatives and uses thereof
|
WO2017180589A1
(en)
|
2016-04-11 |
2017-10-19 |
Auspex Pharmaceuticals, Inc. |
Deuterated ketamine derivatives
|
US10047077B2
(en)
|
2016-04-13 |
2018-08-14 |
Skyline Antiinfectives, Inc. |
Deuterated O-sulfated beta-lactam hydroxamic acids and deuterated N-sulfated beta-lactams
|
EP4190357A1
(de)
|
2016-05-13 |
2023-06-07 |
Institut Pasteur |
Hemmung von beta-2-nikotin-acetylcholinrezeptoren zur behandlung von morbus-alzheimer-pathologie
|
TWI753910B
(zh)
|
2016-05-16 |
2022-02-01 |
美商拜歐斯瑞克斯公司 |
吡啶硫酮、其醫藥組合物及其治療增生性、炎性、神經退化性或免疫介導疾病之治療用途
|
MX2018014387A
(es)
|
2016-05-27 |
2019-03-14 |
Agenus Inc |
Anticuerpos anti proteina inmunoglobulina de linfocitos t y dominio de mucina 3 (tim-3) y métodos para usarlos.
|
CN109715196A
(zh)
|
2016-06-13 |
2019-05-03 |
转矩医疗股份有限公司 |
用于促进免疫细胞功能的组合物和方法
|
WO2017222575A1
(en)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Process of making more stable abuse-deterrent oral formulations
|
MA45602A
(fr)
|
2016-07-08 |
2019-05-15 |
Staten Biotechnology B V |
Anticorps anti-apoc3 et leurs méthodes d'utilisation
|
US11433086B2
(en)
|
2016-08-08 |
2022-09-06 |
Glycomimetics, Inc. |
Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
|
US10919904B2
(en)
|
2016-08-17 |
2021-02-16 |
North Carolina State University |
Northern-southern route to synthesis of bacteriochlorins
|
CN109982687A
(zh)
|
2016-09-19 |
2019-07-05 |
梅制药公司 |
联合疗法
|
WO2018053460A1
(en)
*
|
2016-09-19 |
2018-03-22 |
The Regents Of The University Of California |
Paramagnetic polymers
|
CA3037850A1
(en)
|
2016-10-07 |
2018-04-12 |
Glycomimetics, Inc. |
Highly potent multimeric e-selectin antagonists
|
AU2017343621B2
(en)
|
2016-10-11 |
2021-12-02 |
Agenus Inc. |
Anti-LAG-3 antibodies and methods of use thereof
|
US11779604B2
(en)
|
2016-11-03 |
2023-10-10 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses and methods
|
KR102539159B1
(ko)
|
2016-11-07 |
2023-06-02 |
주식회사 뉴라클사이언스 |
서열 유사성을 가진 항-패밀리 19, 멤버 a5 항체 및 그것의 사용 방법
|
WO2018089692A1
(en)
|
2016-11-09 |
2018-05-17 |
Phloronol, Inc. |
Eckol derivatives, methods of synthesis and uses thereof
|
WO2018089427A1
(en)
|
2016-11-09 |
2018-05-17 |
Novomedix, Llc |
Nitrite salts of 1, 1-dimethylbiguanide, pharmaceutical compositions, and methods of use
|
WO2018102252A1
(en)
|
2016-11-30 |
2018-06-07 |
North Carolina State University |
Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds
|
EP3548007A4
(de)
|
2016-12-01 |
2020-08-12 |
Ignyta, Inc. |
Verfahren zur behandlung von krebs
|
TW202345829A
(zh)
|
2016-12-02 |
2023-12-01 |
美商紐羅克里生物科學有限公司 |
戊苯那嗪(valbenazine)於治療精神分裂症或情感性精神分裂症之用途
|
SI3551660T1
(sl)
|
2016-12-07 |
2024-02-29 |
Agenus Inc. |
Protitelesa proti antictla-4 in načini njihove uporabe
|
EP3551225A1
(de)
|
2016-12-07 |
2019-10-16 |
Agenus Inc. |
Antikörper und verfahren zur verwendung davon
|
MX2019008853A
(es)
|
2017-01-27 |
2019-09-11 |
Neurocrine Biosciences Inc |
Metodos para la administracion de ciertos inhibidores de proteina transportadora transportador de monoamina vesicular-2 (vmat2).
|
BR112019017260A2
(pt)
|
2017-02-17 |
2020-04-14 |
Camris Int Inc |
antiveneno universal
|
NZ755597A
(en)
|
2017-02-17 |
2023-06-30 |
Eidos Therapeutics Inc |
Processes for preparing ag-10, its intermediates, and salts thereof
|
WO2018160752A1
(en)
|
2017-02-28 |
2018-09-07 |
Children's Medical Center Corporation |
Stimuli-responsive particles encapsulating a gas and methods of use
|
WO2018164996A1
(en)
|
2017-03-06 |
2018-09-13 |
Neurocrine Biosciences, Inc. |
Dosing regimen for valbenazine
|
JP7272956B2
(ja)
|
2017-03-15 |
2023-05-12 |
グリコミメティクス, インコーポレイテッド |
E-セレクチンアンタゴニストとしてのガラクトピラノシル-シクロヘキシル誘導体
|
EP3601351A1
(de)
|
2017-03-27 |
2020-02-05 |
Celgene Corporation |
Verfahren und zusammensetzungen zur reduzierung der immunogenität
|
AU2018253176B2
(en)
|
2017-04-13 |
2023-02-02 |
Agenus Inc. |
Anti-CD137 antibodies and methods of use thereof
|
CA3059133A1
(en)
|
2017-04-21 |
2018-10-25 |
Staten Biotechnology B.V. |
Anti-apoc3 antibodies and methods of use thereof
|
WO2018200605A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocrine Biosciences, Inc. |
Use of valbenazine for treating levodopa-induced dyskinesia
|
HRP20230941T1
(hr)
|
2017-05-01 |
2023-11-24 |
Agenus Inc. |
Anti-tigit antitijela i postupci njihove primjene
|
JOP20190219A1
(ar)
|
2017-05-09 |
2019-09-22 |
Cardix Therapeutics LLC |
تركيبات صيدلانية وطرق لعلاج أمراض القلب والأوعية الدموية
|
US10085999B1
(en)
|
2017-05-10 |
2018-10-02 |
Arixa Pharmaceuticals, Inc. |
Beta-lactamase inhibitors and uses thereof
|
CA3064274A1
(en)
|
2017-06-01 |
2018-12-06 |
Xoc Pharmaceuticals, Inc. |
Ergoline derivatives for use in medicine
|
EP3645040A4
(de)
|
2017-06-27 |
2021-05-05 |
Neuracle Science Co., Ltd |
Verwendung von anti-fam19a5-antikörpern zur krebsbehandlung
|
WO2019003162A1
(en)
|
2017-06-27 |
2019-01-03 |
Neuracle Science Co., Ltd. |
USE OF ANTIBODIES DIRECTED AGAINST A SIMILARITY FAMILY OF SEQUENCE 19, MEMBER A5, FOR THE TREATMENT OF GLAUCOMA
|
US11155613B2
(en)
|
2017-06-27 |
2021-10-26 |
Neuracle Science Co., Ltd. |
Use of anti-FAM19A5 antibodies for treating fibrosis
|
CN111315774B
(zh)
|
2017-06-27 |
2023-12-22 |
纽洛可科学有限公司 |
抗fam19a5抗体及其用途
|
AU2018324070B2
(en)
|
2017-09-01 |
2023-05-18 |
East Carolina University |
Compounds, compositions, kits, and methods for activating immune cells and/or an immune system response
|
US11524033B2
(en)
|
2017-09-05 |
2022-12-13 |
Torque Therapeutics, Inc. |
Therapeutic protein compositions and methods of making and using the same
|
MX2020002841A
(es)
|
2017-09-21 |
2020-07-22 |
Neurocrine Biosciences Inc |
Formulacion de valbenazina de alta dosis y composiciones, metodos y kits relacionados con la misma.
|
US20200230127A1
(en)
|
2017-10-10 |
2020-07-23 |
Neurocrine Biosciences, Inc. |
Methods for the Administration of Certain VMAT2 Inhibitors
|
US10993941B2
(en)
|
2017-10-10 |
2021-05-04 |
Neurocrine Biosciences, Inc. |
Methods for the administration of certain VMAT2 inhibitors
|
JP7039694B2
(ja)
|
2017-10-31 |
2022-03-22 |
スターテン・バイオテクノロジー・ベー・フェー |
抗apoc3抗体およびその使用方法
|
JP7275131B2
(ja)
|
2017-11-30 |
2023-05-17 |
グリコミメティクス, インコーポレイテッド |
骨髄浸潤リンパ球を動員する方法、およびその使用
|
JP7304863B2
(ja)
|
2017-12-29 |
2023-07-07 |
グリコミメティクス, インコーポレイテッド |
E-セレクチンおよびガレクチン-3のヘテロ二機能性阻害剤
|
TWI823890B
(zh)
|
2018-01-10 |
2023-12-01 |
美商克拉治療有限責任公司 |
包含苯基磺醯胺之醫藥組合物及其治療應用
|
TW201929847A
(zh)
|
2018-01-10 |
2019-08-01 |
美商克拉治療有限責任公司 |
包含二羧酸之醫藥組合物及其治療應用
|
JP7455064B2
(ja)
|
2018-03-05 |
2024-03-25 |
グリコミメティクス, インコーポレイテッド |
急性骨髄性白血病および関連状態を処置する方法
|
KR20200135996A
(ko)
|
2018-03-23 |
2020-12-04 |
에이도스 테라퓨틱스, 인코포레이티드 |
Ag10을 사용하여 ttr 아밀로이드증을 치료하는 방법
|
CN112424223A
(zh)
|
2018-04-24 |
2021-02-26 |
纽洛可科学有限公司 |
抗序列相似家族19成员a5的抗体在治疗神经性疼痛中的用途
|
WO2019241555A1
(en)
|
2018-06-14 |
2019-12-19 |
Neurocrine Biosciences, Inc. |
Vmat2 inhibitor compounds, compositions, and methods relating thereto
|
CA3105352A1
(en)
|
2018-06-29 |
2020-01-02 |
Histogen, Inc. |
(s)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid derivatives and related compounds as caspase inhibitors for treating cardiovascular diseases
|
MA53160A
(fr)
|
2018-07-20 |
2021-05-26 |
Pf Medicament |
Récepteur pour vista
|
CN112867491A
(zh)
|
2018-08-15 |
2021-05-28 |
纽罗克里生物科学有限公司 |
施用某些vmat2抑制剂的方法
|
US11260047B2
(en)
|
2018-08-17 |
2022-03-01 |
Eidos Therapeutics, Inc. |
Formulations of AG10
|
CN112969503A
(zh)
|
2018-10-03 |
2021-06-15 |
斯塔滕生物技术有限公司 |
对人类和食蟹猕猴apoc3具有特异性的抗体和其使用方法
|
AU2019379325A1
(en)
|
2018-11-16 |
2021-06-03 |
Genexine, Inc. |
Method of treating a tumor with a combination of IL-7 protein and an immune checkpoint inhibitor
|
KR20200071198A
(ko)
|
2018-12-10 |
2020-06-19 |
네오이뮨텍, 인코퍼레이티드 |
Nrf2 발현 조절 기반 T 세포 항암면역치료법
|
JP7407461B2
(ja)
|
2018-12-19 |
2024-01-04 |
シャイ・セラピューティクス・エルエルシー |
がん、炎症性疾患、ras病、及び線維性疾患の処置のためのrasスーパーファミリーと相互作用する化合物
|
US11845771B2
(en)
|
2018-12-27 |
2023-12-19 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectin and galectin-3
|
TW202045481A
(zh)
|
2019-02-06 |
2020-12-16 |
美商戴斯阿爾法股份有限公司 |
Il-17a調節物及其用途
|
EP3930847B1
(de)
|
2019-02-26 |
2024-02-14 |
Inspirna, Inc. |
Anti-mertk-antikörper mit hoher affinität und ihre verwendung
|
EP3935042A1
(de)
|
2019-03-07 |
2022-01-12 |
Conatus Pharmaceuticals, Inc. |
Caspase-inhibitoren und verfahren zur verwendung davon
|
US20220152226A1
(en)
*
|
2019-03-27 |
2022-05-19 |
The Texas A&M University System |
Intracellular delivery and mitochondrial targeting by fluorination
|
CA3138403A1
(en)
|
2019-05-20 |
2020-11-26 |
Christopher J. MACNEVIN |
Narrow emission dyes, compositions comprising same, and methods for making and using same
|
AU2020311404A1
(en)
|
2019-07-11 |
2022-03-03 |
Cura Therapeutics, Llc |
Sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications for the treatment of neurodegenerative diseases
|
US20220274921A1
(en)
|
2019-07-11 |
2022-09-01 |
Cura Therapeutics, Llc |
Phenyl compounds and pharmaceutical compositions thereof, and their therapeutic applications
|
US10940141B1
(en)
|
2019-08-23 |
2021-03-09 |
Neurocrine Biosciences, Inc. |
Methods for the administration of certain VMAT2 inhibitors
|
CN114585644A
(zh)
|
2019-08-30 |
2022-06-03 |
艾吉纳斯公司 |
抗cd96抗体及其使用方法
|
MX2022003166A
(es)
|
2019-09-16 |
2022-06-29 |
Dice Alpha Inc |
Moduladores de il-17a y usos de los mismos.
|
CN114945409A
(zh)
|
2020-01-13 |
2022-08-26 |
新免疫技术有限公司 |
用il-7蛋白和双特异性抗体的组合治疗肿瘤的方法
|
WO2021151001A1
(en)
|
2020-01-22 |
2021-07-29 |
Outpace Bio, Inc. |
Chimeric polypeptides
|
IL294944A
(en)
|
2020-01-28 |
2022-09-01 |
Genentech Inc |
Il15/il15r alpha heterodimeric fc-fused proteins for cancer therapy
|
AU2021217373A1
(en)
|
2020-02-05 |
2022-08-04 |
Neoimmunetech, Inc. |
Method of treating a solid tumor with a combination of an IL-7 protein and CAR-bearing immune cells
|
CA3179635A1
(en)
|
2020-05-29 |
2021-12-02 |
Boulder Bioscience Llc |
Methods for improved endovascular thrombectomy using 3,3'-diindolylmethane
|
EP4168414A1
(de)
|
2020-06-18 |
2023-04-26 |
Shy Therapeutics LLC |
Substituierte thienopyrimidine zur interaktion mit der ras-superfamilie zur behandlung von krebs, entzündlichen erkrankungen, rasopathien und fibrotischen erkrankungen
|
US11484604B2
(en)
|
2020-08-07 |
2022-11-01 |
Fortis Therapeutics, Inc. |
Immunoconjugates targeting CD46 and methods of use thereof
|
WO2022061348A1
(en)
|
2020-09-16 |
2022-03-24 |
Biotheryx, Inc. |
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
WO2022087335A1
(en)
|
2020-10-23 |
2022-04-28 |
Biotheryx, Inc. |
Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
US20240101629A1
(en)
|
2020-11-02 |
2024-03-28 |
Neoimmunetech, Inc. |
Use of interleukin-7 for the treatment of coronavirus
|
KR20230104175A
(ko)
|
2020-11-05 |
2023-07-07 |
네오이뮨텍, 인코퍼레이티드 |
Il-7 단백질과 뉴클레오타이드 백신의 조합물을 사용한 종양의 치료 방법
|
AU2021402911A1
(en)
|
2020-12-14 |
2023-07-06 |
Biotheryx, Inc. |
Pde4 degraders, pharmaceutical compositions, and therapeutic applications
|
CN114762679B
(zh)
*
|
2021-01-13 |
2023-04-07 |
上海交通大学医学院 |
一种纳米复合物及其制备方法和用途
|
WO2022165000A1
(en)
|
2021-01-27 |
2022-08-04 |
Shy Therapeutics, Llc |
Methods for the treatment of fibrotic disease
|
EP4284377A1
(de)
|
2021-01-27 |
2023-12-06 |
Shy Therapeutics LLC |
Verfahren zur behandlung von fibrotischen erkrankungen
|
CN117642396A
(zh)
|
2021-03-10 |
2024-03-01 |
戴斯分子Sv有限公司 |
αVβ6和αVβ1整联蛋白抑制剂及其用途
|
EP4326721A1
(de)
|
2021-04-22 |
2024-02-28 |
Protego Biopharma, Inc. |
Spirocyclische imidazolidinone und imidazolidindione zur behandlung von leichtkettiger amyloidose
|
EP4347568A1
(de)
|
2021-05-27 |
2024-04-10 |
Protego Biopharma, Inc. |
Heteroaryldiamid-ire1/xbp1s-aktivatoren
|
WO2022251644A1
(en)
|
2021-05-28 |
2022-12-01 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
KR20240027676A
(ko)
|
2021-06-02 |
2024-03-04 |
라이엘 이뮤노파마, 인크. |
Nr4a3-결핍 면역 세포 및 이의 용도
|
WO2022263357A1
(en)
|
2021-06-14 |
2022-12-22 |
Argenx Iip Bv |
Anti-il-9 antibodies and methods of use thereof
|
WO2022266248A1
(en)
|
2021-06-16 |
2022-12-22 |
Biotheryx, Inc. |
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
WO2022266249A1
(en)
|
2021-06-16 |
2022-12-22 |
Biotheryx, Inc. |
Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
WO2023055045A1
(ko)
|
2021-09-29 |
2023-04-06 |
주식회사 엔바이오스 |
코일드 코일 융합 단백질
|
WO2023081923A1
(en)
|
2021-11-08 |
2023-05-11 |
Frequency Therapeutics, Inc. |
Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof
|
WO2023130081A1
(en)
|
2021-12-30 |
2023-07-06 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of il-7 protein and vegf antagonist
|
WO2023129577A1
(en)
|
2022-01-03 |
2023-07-06 |
Lilac Therapeutics, Inc. |
Cyclic thiol prodrugs
|
US20230348909A1
(en)
|
2022-03-30 |
2023-11-02 |
Biomarin Pharmaceutical Inc. |
Dystrophin exon skipping oligonucleotides
|
GB2619907A
(en)
|
2022-04-01 |
2023-12-27 |
Kanna Health Ltd |
Novel crystalline salt forms of mesembrine
|
WO2023201282A1
(en)
|
2022-04-14 |
2023-10-19 |
Bristol-Myers Squibb Company |
Novel gspt1 compounds and methods of use of the novel compounds
|
US20230416741A1
(en)
|
2022-05-05 |
2023-12-28 |
Biomarin Pharmaceutical Inc. |
Method of treating duchenne muscular dystrophy
|
WO2023220640A1
(en)
|
2022-05-10 |
2023-11-16 |
Biotheryx, Inc. |
Cdk protein degraders, pharmaceutical compositions, and therapeutic applications
|
WO2023225665A1
(en)
|
2022-05-19 |
2023-11-23 |
Lyell Immunopharma, Inc. |
Polynucleotides targeting nr4a3 and uses thereof
|
US20230399362A1
(en)
|
2022-06-13 |
2023-12-14 |
B.A.I. Laboratories, Llc |
Interleukin-13 binding cyclic oligopeptides and methods of use thereof
|
WO2024054832A1
(en)
|
2022-09-09 |
2024-03-14 |
Innovo Therapeutics, Inc. |
CK1α AND DUAL CK1α / GSPT1 DEGRADING COMPOUNDS
|
WO2024073473A1
(en)
|
2022-09-30 |
2024-04-04 |
Boulder Bioscience Llc |
Compositions comprising 3,3'-diindolylmethane for treating non-hemorrhagic closed head injury
|